PPT-Biomarkers & Pharmacogenomics

in CNS disorders Subbu Apparsundaram PhD CSO V ClinBio subbuvclinbiocom 1 862 485 7489 wwwvclinbiocom Sri Ramachandra University Porur Chennai India omics based prediction of drug response profiling. in CNS disorders. Subbu. . Apparsundaram. , PhD. CSO, V . ClinBio. subbu@vclinbio.com. +1 862 485 7489. www.vclinbio.com. Sri Ramachandra University. Porur. , Chennai, India. . omics. based prediction of drug response profiling. FAINELLI . Manon. BOGÓ . Ákos. . Szakács . Júlia . M.D. . . Department of Pathophysiology. Numbers…. Cardiovascular diseases . The most frequent cause of death. 7.5 millions of death/ year. Important concerns in developed countries. James L. Cook, DVM, . PhD. Director, Comparative Orthopaedic Lab & . Mizzou. . BioJoint. Center. cookjl@health.missouri.edu. Osteoarthritis (OA): . Everyone’s Problem. Markets. Canine. 78M companion dogs in US (2015 APPA Survey). Methods in Clinical Cancer Research. February 12, 2015. Effective incorporation of . biomarkers into phase II trials. There are many roles for biomarkers in Phase II trial designs.. Examples of biomarkers with pivotal role in development of new therapies. in CNS disorders. Subbu. . Apparsundaram. , PhD. CSO, V . ClinBio. subbu@vclinbio.com. 1 862 485 7489. www.vclinbio.com. Sri Ramachandra University. Porur. , Chennai, India. . omics. based prediction of drug response profiling. NELLE FASI INIZIALI DI DEMENZA. Dr. Filippo Baldacci . 5 -7 Aprile 2019, Viareggio. III Meeting delle . Neuroscienze. Toscane. Abbreviations: A. β42, . amyloid‑. β42; . ALS, amyotrophic lateral sclerosis; . Filipa Mendes. Center. for Nuclear Sciences . and. Technologies. IST, Universidade de Lisboa .  . Summer school . Development and Pre-clinical Evaluation of Radiopharmaceuticals. Molecular . and. Cell . Schistosoma mansoni. in . Biomphalaria glabrata. Benson Otarigho. 1,3. ,. , . Leandro Xavier Neves. 2. , . Ananda. Lima Sanson. 2. , . Mofolusho. O. Falade. 1. , William Castro-Borges. 2. 1. Cellular Parasitology . Optimist. Department of Biochemistry, Molecular Biology and Biophysics. Institute on Biology of Aging and Metabolism. lniedern. @. umn.edu. Utility of mice in biomarker discovery. Strength . of mice. a measurable indicator . that . can . tell . us something about a person’s health or disease . state, for example, . disease (pathological) processes in the body, for example, disease stage. , . biological processes in the body (heart rate, blood pressure, temperature), . Authors: . Kieu Vu, John . Arend. , Nichole . Cadez. , Deb Darnell, Valerie . Somma. , . Randi Rycroft, . Loria. Pollack, . Paran. . Pordell. . Women’s Wellness Connection. BCCP (Triple negative breast cancer). Presented by: . Dr. Puneet Opal . Dr. Hayley McLoughlin. A Virtual Event. March 17-19, 2022. DISCLAIMER. 2022 AAC. A Virtual Event. March 17-19. PRESENTER DISCLOSURES. Dr. Puneet Opal (Northwestern University). Leyen. Vu, DO. Sept. 8. th. , 2018. WSU Cougar Health Services. WSU Athletics Team Physician. Objectives. Need for objective measures for concussion. Identify characteristics of ideal serum biomarkers for concussion. Nfl. =neurofilament light; PDGFR. . =. platelet-derived growth factor receptor beta. ; . PET=positron emission tomography; p-tau=phosphorylated tau; RT-. QuIC. =real-time quaking-induced conversion; SNAP-25=.